Handelsbanken Fonder
ARRY

Handelsbanken Fonder’s Array Biopharma Inc ARRY Stock Holding History

Handelsbanken Fonder’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-795,712
Closed -$36.9M – 200
2019
Q2 		$36.9M Sell
795,712
-270,000
-25% -$7.58M 0.68% 43
2019
Q1 		$26M Sell
1,065,712
-594,919
-36% -$12.4M 0.5% 59
2018
Q4 		$23.7M Buy
1,660,631
+237,631
+17% +$3.6M 0.48% 64
2018
Q3 		$21.6M Buy
1,423,000
+430,000
+43% +$6.59M 0.41% 76
2018
Q2 		$16.7M Sell
993,000
-110,000
-10% -$1.75M 0.33% 92
2018
Q1 		$18M Buy
1,103,000
+70,000
+7% +$1.12M 0.35% 85
2017
Q4 		$13.2M Buy
1,033,000
+465,000
+82% +$5.29M 0.29% 90
2017
Q3 		$6.99M Buy
568,000
+88,000
+18% +$817K 0.16% 119
2017
Q2 		$4.02M Buy
480,000
+310,000
+182% +$2.54M 0.1% 140
2017
Q1 		$1.52M Sell
170,000
-10,000
-6% -$106K 0.04% 149
2016
Q4 		$1.58M Buy
180,000
+50,000
+38% +$368K 0.05% 138
2016
Q3 		$878K Buy
+130,000
New +$503K 0.03% 150

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Handelsbanken Fonder's ARRY Position: Q3 2019 in Review

Handelsbanken Fonder sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 795,712 shares — an estimated $36.9M sold.

Handelsbanken Fonder first reported a position in ARRY in Q3 2016 and held it in 12 quarters. The position peaked at $36.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Handelsbanken Fonder reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Handelsbanken Fonder sold 795,712 Array Biopharma Inc shares in Q3 2019, an estimated $36.9M.
  • Handelsbanken Fonder first reported a position in Array Biopharma Inc in Q3 2016 and held it in 12 quarters.
  • Handelsbanken Fonder's Array Biopharma Inc position peaked at $36.9M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Handelsbanken Fonder's 13F filing for Q3 2019, filed 31 Oct 2019.